MyoGene Bio: Funding, Investors & Team (Sep 2026)
MyoGene Bio develops therapies for muscle diseases, starting with a gene-editing therapy for Duchenne muscular dystrophy.
MyoGene Bio has raised $400k across 2 funding rounds on record, the most recent an undisclosed round of $400k announced in Nov 2025.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
MyoGene Bio Company Profile and Key Stats
Latest funding round on record: Nov 2025.
MyoGene Bio Funding Rounds
1 of 2 rounds was announced without a disclosed amount and is excluded from the total.
MyoGene Bio announced an undisclosed round in May 2023; the amount was not disclosed.
2.5 years later, an undisclosed round of $400k was announced in Nov 2025.
MyoGene Bio Founders and Leadership Team
Contact details for the MyoGene Bio team: 1 has a LinkedIn profile.
Start 14-day free trial →MyoGene Bio Funding Compared to Other Biotechnology Startups
MyoGene Bio's latest round of $400k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like MyoGene Bio in Biotechnology and Los Angeles
Companies Similar to MyoGene Bio
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
MyoGene Bio Funding FAQs
What does MyoGene Bio do?
MyoGene Bio develops therapies for muscle diseases, starting with a gene-editing therapy for Duchenne muscular dystrophy.
How much funding has MyoGene Bio raised?
MyoGene Bio has raised $400k across 2 rounds on record. The most recent is an undisclosed round of $400k announced in Nov 2025.
When did MyoGene Bio last raise funding?
MyoGene Bio's most recent funding round on record is an undisclosed round of $400k, announced in Nov 2025.
Who founded MyoGene Bio?
FundedIQ lists Courtney Young (Founder) at MyoGene Bio.
Where is MyoGene Bio headquartered?
MyoGene Bio is based in Los Angeles, California, United States.
How many employees does MyoGene Bio have?
MyoGene Bio is in the 1-10 employee band.
How does MyoGene Bio's funding compare to other Biotechnology startups?
MyoGene Bio's latest round of $400k is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's MyoGene Bio Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for MyoGene Bio is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.